Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis.

AUTOR(ES)

Giron, J A

RESUMO

The pharmacokinetics of piperacillin administered intravenously were studied in five patients with stable mild to moderate renal impairment and in five patients undergoing hemodialysis. Patients with stable renal failure given 1 g of piperacillin intravenously had peak serum concentrations within 30 min ranging from 78 to 280 micrograms/ml. The mean serum half-life was 3.57 +/- 1.36 h; the mean apparent volume of distribution was 28.6 +/- 13.5 liters/100 kg; and the plasma clearance was 4.10 +/- 1.46 liters/h per 1.73 m2. Neither serum half-life nor clearance correlated with serum creatinine, implying significant nonrenal elimination. Patients undergoing hemodialysis had peak serum concentrations within 30 min of 66 to 138 micrograms/ml after 1 g of piperacillin infused intravenously. During hemodialysis, the serum half-life was 3.6 +/- 2.5 h; the mean apparent volume of distribution was 26.7 +/- 16.7 liters/100 kg; and the plasma clearance was 3.28 +/- 0.76 layers/h per 1.73 m2. Mean hemodialysis clearance was 0.484 +/- 0.282 liters/h per 1.73 m2, and only 10.0 +/- 5.3% of the total dose could be recovered in the dialysate.

Documentos Relacionados

• Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis.
• Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.
• Pharmacokinetics of moxalactam in patients with renal failure and during hemodialysis.
• Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
• Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.